BiDe Pharmaceutical: Net profit in 2025 is 152 million yuan, a year-on-year increase of 29.61%

Bide Pharmaceutical released its performance report, achieving operating income of 1.324 billion yuan in 2025, a year-on-year increase of 20.13%; achieving a net profit attributable to the owner of the parent company of 152 million yuan, a year-on-year increase of 29.61%; achieving a net profit attributable to the owner of the parent company, excluding non-recurring gains and losses, of 133 million yuan, a year-on-year increase of 27.98%. During the reporting period, the company adhered to a globalization development strategy, while focusing on expanding the domestic market, it continuously strengthened marketing and promotion activities for overseas business, which continued to grow. The company actively increased product innovation, continuously optimized product structure, promoted research and development to create value, continuously promoted intelligent operation, steadily increased operating income, and improved profitability indicators such as gross margin and profit margin.